About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Clinical Onco-Immunology
›
top-articles
Division of Clinical Onco-Immunology
129
(top 1%)
papers
9.4K
(top 1%)
citations
53
(top 1%)
h
-index
96
(top 1%)
g
-index
132
all documents
9.7K
doc citations
1.2K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
Journal of Clinical Investigation
2005
569
2
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes
Journal of Experimental Medicine
1998
475
3
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals
Journal of Experimental Medicine
1999
447
4
Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues
Journal of Immunology
1998
370
5
Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes
Journal of Immunology
2007
347
6
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
Journal of Immunology
1998
329
7
Cross-Priming of Naive Cd8 T Cells against Melanoma Antigens Using Dendritic Cells Loaded with Killed Allogeneic Melanoma Cells
Journal of Experimental Medicine
2000
259
8
Human natural Treg microRNA signature: Role of microRNA‐31 and microRNA‐21 in FOXP3 expression
European Journal of Immunology
2009
252
9
Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression
Journal of Immunology
2000
232
10
Cross-presenting human γδ T cells induce robust CD8
+
αβ T cell responses
Proceedings of the National Academy of Sciences of the United States of America
2009
229
11
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
Cancer Immunology, Immunotherapy
2008
193
12
In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes
Journal of Experimental Medicine
1999
179
13
“MIATA”—Minimal Information about T Cell Assays
Immunity
2009
178
14
Toll‐like receptors’ two‐edged sword: when immunity meets apoptosis
European Journal of Immunology
2007
156
15
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients
Cancer Research
2000
140
16
Cooperation of Human Tumor-Reactive CD4+ and CD8+ T Cells after Redirection of Their Specificity by a High-Affinity p53A2.1-Specific TCR
Immunity
2005
136
17
Ex Vivo IFN-γ Secretion by Circulating CD8 T Lymphocytes: Implications of a Novel Approach for T Cell Monitoring in Infectious and Malignant Diseases
Journal of Immunology
2001
135
18
Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay: a four-centre comparative trial
Journal of Immunological Methods
2000
131
19
T Cell Assays and MIATA: The Essential Minimum for Maximum Impact
Immunity
2012
131
20
TRAF2 Deficiency Results in Hyperactivity of Certain TNFR1 Signals and Impairment of CD40-Mediated Responses
Immunity
1999
128
21
Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance
Journal of Experimental Medicine
2002
120
22
Vaccination with a Melan-A Peptide Selects an Oligoclonal T Cell Population with Increased Functional Avidity and Tumor Reactivity
Journal of Immunology
2002
113
23
In vivo
imaging of T cell delivery to tumors after adoptive transfer therapy
Proceedings of the National Academy of Sciences of the United States of America
2007
113
24
Human Effector CD8+ T Lymphocytes Express TLR3 as a Functional Coreceptor
Journal of Immunology
2006
112
25
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients
European Journal of Immunology
1999
111
26
Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma
Journal of Immunology
2002
106
27
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity
Cancer Research
2001
106
28
Enrichment of Human CD4+ Vα24/Vβ11 Invariant NKT Cells in Intrahepatic Malignant Tumors
Journal of Immunology
2009
103
29
In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells
European Journal of Immunology
2002
96
30
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma
Blood
2007
95
31
Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+ CD8+ T Cells in Humans
Journal of Experimental Medicine
2002
90
32
Naturally Acquired MAGE-A10- and SSX-2-Specific CD8+ T Cell Responses in Patients with Hepatocellular Carcinoma
Journal of Immunology
2005
89
33
Tetramer-Guided Analysis of TCR β-Chain Usage Reveals a Large Repertoire of Melan-A-Specific CD8+ T Cells in Melanoma Patients
Journal of Immunology
2000
84
34
The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector αβ T Cells
Journal of Immunology
2001
82
35
Discrepancy between ELISPOT IFN- secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life
Proceedings of the National Academy of Sciences of the United States of America
2001
82
36
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells
Immunology
2005
80
37
MicroRNA Profile of Circulating CD4-positive Regulatory T Cells in Human Adults and Impact of Differentially Expressed MicroRNAs on Expression of Two Genes Essential to Their Function
Journal of Biological Chemistry
2012
80
38
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
Trends in Molecular Medicine
1998
78
39
A Novel Approach to Characterize Clonality and Differentiation of Human Melanoma-Specific T Cell Responses: Spontaneous Priming and Efficient Boosting by Vaccination
Journal of Immunology
2006
78
40
Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue
Journal of Immunology
2000
75
41
TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions
European Journal of Immunology
2000
72
42
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity
Cancer Research
2002
70
43
Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR
Journal of Immunology
2002
67
44
α3 Domain Mutants of Peptide/MHC Class I Multimers Allow the Selective Isolation of High Avidity Tumor-Reactive CD8 T Cells
Journal of Immunology
2003
65
45
Selective accumulation of differentiated FOXP3+ CD4+ T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood
Cancer Immunology, Immunotherapy
2008
65
46
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond
Cancer Immunology, Immunotherapy
2011
65
47
High Frequency of Functionally Active Melan-A–Specific T Cells in a Patient with Progressive Immunoproteasome-Deficient Melanoma
Cancer Research
2004
60
48
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
Cancer Immunology, Immunotherapy
2009
60
49
Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL
Journal of Immunology
2002
57
50
The Human T Cell Response to Melanoma Antigens
Advances in Immunology
2006
56
site/software ©
exaly
; All materials licenced under
CC by-SA
.